Manuela Arbune
Impact in
- Virology top 5%
- HIV Research and Treatment
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- HIV/AIDS Research and Interventions 7
- COVID-19 Clinical Research Studies 6
- HIV/AIDS drug development and treatment 4
- Epidemiology 28
- Hepatitis B Virus Studies 5
- Co-authors
- Alin Laurențiu Tatu (11 shared papers)Alina Viorica Iancu (15 shared papers)Elena Niculeț (9 shared papers)Silvia Fotea (3 shared papers)Gabriela Gurău (8 shared papers)Aurel Nechita (6 shared papers)Anca-Adriana Arbune (18 shared papers)Magdalena Miulescu (2 shared papers)
- Journals
- Viruses (3 papers)BMC Infectious Diseases (3 papers)Journal of Clinical Medicine (3 papers)Journal of Hepatology (3 papers)Pathogens (2 papers)
- Partner nations
- RomaniaUnited StatesUnited Kingdom
In The Last Decade
Manuela Arbune
65 papers receiving 905 citations
Manuela Arbune's Hit Papers
Peers
Comparison fields: 5 of 102
- Virology 107
- Molecular Medicine 103
- Infectious Diseases 361
- Applied Microbiology and Biotechnology 32
- Hepatology 115
Countries citing papers authored by Manuela Arbune
This map shows the geographic impact of Manuela Arbune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Arbune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Arbune more than expected).
Fields of papers citing papers by Manuela Arbune
This network shows the impact of papers produced by Manuela Arbune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Arbune. The network helps show where Manuela Arbune may publish in the future.
Co-authors
The 25 scholars most cited alongside Manuela Arbune, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials Hit paper breakdown → | 2018 | 313 |
| 2 | Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection Hit paper breakdown → | 2022 | 188 |
| 3 | 2020 | 79 | |
| 4 | 2021 | 54 | |
| 5 | 2021 | 47 | |
| 6 | 2020 | 30 | |
| 7 | 2018 | 17 | |
| 8 | 2015 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2023 | 12 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 10 | |
| 13 | 2016 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2016 | 6 | |
| 19 | Respiratory infections and air pollution, retrospective study over the past 10 years. | 2018 | 4 |
| 20 | 2023 | 4 |
About Manuela Arbune
Manuela Arbune is a scholar working on Infectious Diseases, Epidemiology, Oncology, Emergency Medicine and Applied Microbiology and Biotechnology, having authored 77 papers that have together received 932 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (8 papers), HIV/AIDS Research and Interventions (7 papers), HIV-related health complications and treatments (7 papers), COVID-19 Clinical Research Studies (6 papers), Hepatitis B Virus Studies (5 papers), Long-Term Effects of COVID-19 (4 papers), HIV/AIDS drug development and treatment (4 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Virology (107 citations), Molecular Medicine (103 citations), Infectious Diseases (361 citations), Applied Microbiology and Biotechnology (32 citations) and Hepatology (115 citations). Manuela Arbune has collaborated with scholars based in Romania, United States and United Kingdom. Frequent co-authors include Alin Laurențiu Tatu, Alina Viorica Iancu, Elena Niculeț, Silvia Fotea, Gabriela Gurău, Aurel Nechita, Anca-Adriana Arbune, Magdalena Miulescu, Liliana Baroiu and Mariana Carmen Chifiriuc. Their work appears in journals such as Viruses, BMC Infectious Diseases, Journal of Clinical Medicine, Journal of Hepatology and Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.